News Announcement

Caplin Point Laboratories: Announcement under Regulation 30 (LODR)-Press Release / Media Release

Press Release regarding receipt of final approval by our Subsidiary Caplin Steriles Limited from the USFDA for the ANDA Methylprednisolone Acetate Injectable Suspension USP.

Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.